13
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Myelodysplastic Syndrome During Recombinant Human Growth Hormone Supplementation After Treatment for Neuroblastoma

, , , , &
Pages 571-575 | Received 11 Dec 1995, Accepted 14 Mar 1996, Published online: 09 Jul 2009

References

  • Stahnke N. Leukemia in growth-hormone-treated patients: an update. Horm Res. 1992; 38: 56–62
  • Shalet S M. Leukemia in children treated with growth hormone. J Pediatr Endocrinol. 1993; 6: 109–111
  • Watanabe S, Tsunematsu Y, Fujimoto J, Komiyama A. Leukemia in patients treated with growth hormone. Lancet. 1988; 1159
  • Watanabe S, Mizuno S, Oshima L-H, Tsunematsu Y, Fujimoto J, Komiyama A. Leukemia and other malignancies among GH users. J Pediatr Endocrinol. 1993; 6: 99–108
  • Fradkin J E, Mills J L, Schonberger L B. Risk of leukemia after treatment with pituitary growth hormone. JAMA 1993; 270: 2829–2832
  • Blatt J. Growth hormone and leukemia. Pediatr Hematol Oncol. 1993; 10: 3–5
  • Levine E G, Bloomfield C D. Leukemia and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure (review). Semin Oncol. 1992; 19: 47–84
  • Ellis M, Lishner M. Second malignancies following treatment in non-Hodgkin's lymphoma (review). Leuk Lymphoma. 1993; 9: 337–342
  • Estrov Z, Meir R, Barak Y, Zadik Z. Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol. 1991; 9: 394–399

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.